About Us

Company Vision

Ibis Vision Limited was set up to complete the development and commercialise a unique software program for visual field tests researched over several years. The resulting application is called 'Ring of Sight' and this test platform can aid the diagnosis and follow-up care of patients with glaucoma.

The Ring of Sight (RoS) platform is designed for use by optometrists, eye surgeons and hospital clinics both in the developed and in the developing world where, because of its low cost and potential portability it will prove invaluable. Future development includes a domiciliary version for use by optometrists & patients at home.

Over the next 24 months additional eye tests will be added to the suite, further enhancing the RoS proposition for our customers. With global demand for a low cost, portable field test RoS is ideally situated to deliver a solution to this market.

Health professionals who have an existing method of field testing recognise RoS as an enhancement for many reasons – not least of which is that it is preferred by patients.

View Product Page

The Team

Mark Roger

CEO

Mark Roger provides a wealth of experience in commercial and strategic development having managed, consulted and acted at executive and non executive director level for numerous IT companies over the last 12+ years.

Justin Birley

Service Director

Justin has over 20 years of sales, marketing and business development experience in pharmaceuticals & medical devices. He has spent the last 5 years working as a Business Development Director in the Scottish SME community within a number of start up companies, creating commercial opportunities for products and services in the UK and globally. Justin has a specific interest in med-tech solutions for the developing world.

Mr David Teenan

Board Member & Clinical Adviser

An experienced ophthalmic surgeon, Mr. David Teenan has performed more than 41,000 procedures including LASIK and LASEK, with specialist interests in cataract and refractive surgery, cornea and external diseases. He is the UK Medical Director of the Optical Express International Medical Advisory Board (IMAB) and is registered with the General Medical Council (GMC) and the Ireland Medical Council (IMC).

Dr Savvas Neophytou

Non Exec Board Member

Savvas is the Head of Life Sciences at Deepbridge. Prior to joining Deepridge, Savvas enjoyed a 15 year career in the City, working as an investment banker at JP Morgan, Bear Stearns, Shore Capital, Cantor Fitzgerald, and Panmure Gordon. Savvas was also CEO of telemedicine business Now Healthcare Group. As a highly acclaimed analyst, Savvas has won multiple Industry awards. Savvas holds a PhD in psychopharmacology from Nottingham University and a BSc (Hons) degree in pharmacology from Manchester University.

Michiel Smith

Non Exec Board Member

Michiel is an experienced Non-Executive Director and informal investor. He is the Gatekeeper of Apollo Informal Investments and currently a Non-Executive Director with several different start ups. He was born in the Netherlands where he obtained a master's degree in Financial Business Economics and a post-graduate master in Financial Analysis. After completing his studies, he worked as an Equity Analyst, covering the retail, leisure and transport sectors. He was also responsible for setting up the Socially Responsible Investment methodology within the Rabo Bank Group